Skip to main content

Radiation Therapy Significantly Improves Survival Of Patients With Diffuse Large B-Cell Lymphoma Associated With MYC Translocation: A Report From The International DLBCL Rituximab-CHOP Consortium Program

Publication ,  Conference
Xu-Monette, ZY; Dabaja, BS; Tzankov, A; Visco, C; Miranda, RN; Dybkaer, K; Chiu, A; Orazi, A; Zu, Y; Bhagat, G; Richards, KL; Hsi, ED; Huh, J ...
Published in: Blood
November 15, 2013

Duke Scholars

Published In

Blood

DOI

EISSN

1528-0020

ISSN

0006-4971

Publication Date

November 15, 2013

Volume

122

Issue

21

Start / End Page

213 / 213

Publisher

American Society of Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Xu-Monette, Z. Y., Dabaja, B. S., Tzankov, A., Visco, C., Miranda, R. N., Dybkaer, K., … Young, K. H. (2013). Radiation Therapy Significantly Improves Survival Of Patients With Diffuse Large B-Cell Lymphoma Associated With MYC Translocation: A Report From The International DLBCL Rituximab-CHOP Consortium Program. In Blood (Vol. 122, pp. 213–213). American Society of Hematology. https://doi.org/10.1182/blood.v122.21.213.213
Xu-Monette, Zijun Y., Bouthaina S. Dabaja, Alexander Tzankov, Carlo Visco, Roberto N. Miranda, Karen Dybkaer, April Chiu, et al. “Radiation Therapy Significantly Improves Survival Of Patients With Diffuse Large B-Cell Lymphoma Associated With MYC Translocation: A Report From The International DLBCL Rituximab-CHOP Consortium Program.” In Blood, 122:213–213. American Society of Hematology, 2013. https://doi.org/10.1182/blood.v122.21.213.213.
Xu-Monette ZY, Dabaja BS, Tzankov A, Visco C, Miranda RN, Dybkaer K, et al. Radiation Therapy Significantly Improves Survival Of Patients With Diffuse Large B-Cell Lymphoma Associated With MYC Translocation: A Report From The International DLBCL Rituximab-CHOP Consortium Program. In: Blood. American Society of Hematology; 2013. p. 213–213.
Xu-Monette, Zijun Y., et al. “Radiation Therapy Significantly Improves Survival Of Patients With Diffuse Large B-Cell Lymphoma Associated With MYC Translocation: A Report From The International DLBCL Rituximab-CHOP Consortium Program.” Blood, vol. 122, no. 21, American Society of Hematology, 2013, pp. 213–213. Crossref, doi:10.1182/blood.v122.21.213.213.
Xu-Monette ZY, Dabaja BS, Tzankov A, Visco C, Miranda RN, Dybkaer K, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WL, Van Krieken JHJM, Huh J, Ai WZ, Ponzoni M, Ferreri A, Moller MB, Zhao X, Go RS, Winter JN, Piris MAA, McDonnell TJ, Li Y, Medeiros LJ, Young KH. Radiation Therapy Significantly Improves Survival Of Patients With Diffuse Large B-Cell Lymphoma Associated With MYC Translocation: A Report From The International DLBCL Rituximab-CHOP Consortium Program. Blood. American Society of Hematology; 2013. p. 213–213.

Published In

Blood

DOI

EISSN

1528-0020

ISSN

0006-4971

Publication Date

November 15, 2013

Volume

122

Issue

21

Start / End Page

213 / 213

Publisher

American Society of Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology